company background image
EVAN

Evans Medical NGSE:EVANSMED Stock Report

Last Price

₦0.50

Market Cap

₦366.2m

7D

0%

1Y

0%

Updated

24 Jun, 2023

Data

Company Financials

EVANSMED Stock Overview

Evans Medical Plc manufactures, markets, and distributes health products.

EVANSMED fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Evans Medical Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Evans Medical
Historical stock prices
Current Share Price₦0.50
52 Week High₦0
52 Week Low₦0
Beta0
1 Month Change0%
3 Month Change0%
1 Year Change0%
3 Year Change0%
5 Year Change0%
Change since IPO-51.11%

Recent News & Updates

Recent updates

Shareholder Returns

EVANSMEDNG PharmaceuticalsNG Market
7D0%3.8%2.7%
1Y0%20.1%114.5%

Return vs Industry: EVANSMED underperformed the NG Pharmaceuticals industry which returned 85.1% over the past year.

Return vs Market: EVANSMED underperformed the NG Market which returned 52.6% over the past year.

Price Volatility

Is EVANSMED's price volatile compared to industry and market?
EVANSMED volatility
EVANSMED Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement8.9%
10% most volatile stocks in NG Market12.0%
10% least volatile stocks in NG Market4.3%

Stable Share Price: EVANSMED has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine EVANSMED's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1954n/an/a

Evans Medical Plc manufactures, markets, and distributes health products. The company operates in the Over the Counter and Prescriptive segments. Its products include anti-malarials, ant-infectives, anti-asthamatics, anti-histaminics, analgesics, anti-ulcerants, anti-hypertensives, anti-diabetics, cold and cough preparations, erectile dysfunctions, energy supplements, herbal products, haematinics blood forming preparations, prostagladins, vitamins and minerals, topical preparations, and pharyngeals.

Evans Medical Plc Fundamentals Summary

How do Evans Medical's earnings and revenue compare to its market cap?
EVANSMED fundamental statistics
Market cap₦366.17m
Earnings (TTM)-₦964.84m
Revenue (TTM)₦3.34b

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EVANSMED income statement (TTM)
Revenue₦3.34b
Cost of Revenue₦1.96b
Gross Profit₦1.39b
Other Expenses₦2.35b
Earnings-₦964.84m

Last Reported Earnings

Dec 31, 2014

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did EVANSMED perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.